Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Overcoming Logistical Hurdles in Bispecific Therapy Implementation
Panelists discuss the most common logistical challenges encountered when implementing bispecific therapies in both academic and community settings.
EP: 1.ASH 2024 Updates on Bispecific Therapies in B-Cell Lymphomas
EP: 2.Emerging Data for Odronextamab in DLBCL
EP: 3.Sequencing Consequences for Earlier Line Use of Bispecifics in B-Cell Lymphomas
EP: 4.Exploring Bispecifics in Earlier Lines of Therapy for B-Cell Lymphomas
EP: 5.ASH 2024 Highlights: Bispecifics in Combination Therapies for B-Cell Lymphomas
EP: 6.MAIC Analyses and Bispecific Therapies: Guiding Treatment Decisions in B-Cell Lymphomas
EP: 7.Understanding CRS and ICANS: Real-World Incidence and Key Patient Risk Factors
EP: 8.Key Strategies for Preventing CRS and ICANS
EP: 9.Step-Up Dosing Protocols and Infection Prevention Strategies for Bispecifics in B-Cell Lymphomas
Now Viewing
EP: 10.Overcoming Logistical Hurdles in Bispecific Therapy Implementation
Video content above is prompted by the following:
- What are the most common logistical challenges you encounter when implementing bispecific therapies in both academic and community settings? (Dr Allan)
Related Videos
